Comparative analysis among therapeutic modalities in ruptured hepatocellular carcinoma and identification of imaging predictors for survival
TAE and surgical treatments provide comparable survival benefits for rHCC patients, extending survival time by approximately 2 months compared to best supportive care. We strongly recommend active management for all rHCC patients whenever possible.
Authors
- Natthaphong Nimitrungtawee (ORCID: https://orcid.org/0000-0001-5239-0969)
- Phichayut Phinyo (ORCID: https://orcid.org/0000-0002-8543-6254)
- Piemkamol Chalidapong
- Nakarin Inmutto (ORCID: https://orcid.org/0000-0002-5667-9986)
Institutions
- Chiang Mai University (TH)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-08-26
- DOI
- https://doi.org/10.1186/s12885-024-12829-y
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00